VHCP Management as of Dec. 31, 2014
Portfolio Holdings for VHCP Management
VHCP Management holds 20 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Juno Therapeutics | 20.4 | $74M | 1.7M | 42.47 | |
| Avalanche Biotechnologies In | 20.0 | $73M | 1.4M | 52.56 | |
| Anacor Pharmaceuticals In | 10.4 | $38M | 1.2M | 32.25 | |
| Dbv Technologies | 9.9 | $36M | 694k | 51.75 | |
| BioCryst Pharmaceuticals (BCRX) | 5.8 | $21M | 1.7M | 12.16 | |
| Gw Pharmaceuticals Plc ads | 5.8 | $21M | 312k | 67.68 | |
| Zafgen | 4.6 | $17M | 542k | 30.84 | |
| Dyax | 3.9 | $14M | 1.0M | 14.06 | |
| Coherus Biosciences (CHRS) | 3.5 | $13M | 870k | 14.47 | |
| Heron Therapeutics (HRTX) | 3.0 | $11M | 1.1M | 10.06 | |
| Radius Health | 2.5 | $9.1M | 233k | 38.91 | |
| Flamel Technologies | 2.4 | $8.6M | 500k | 17.13 | |
| D Stemline Therapeutics | 1.7 | $6.1M | 356k | 17.06 | |
| Ocera Therapeutics | 1.2 | $4.5M | 704k | 6.37 | |
| Zs Pharma | 1.1 | $4.2M | 100k | 41.57 | |
| Ohr Pharmaceutical | 1.1 | $4.0M | 477k | 8.34 | |
| Therapeuticsmd | 1.0 | $3.8M | 847k | 4.45 | |
| Lipocine | 1.0 | $3.5M | 670k | 5.26 | |
| Cynapsus Therapeutics | 0.4 | $1.5M | 1.5M | 0.95 | |
| Sunesis Pharmaceuticals | 0.4 | $1.4M | 536k | 2.55 |
